DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▼ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | MGAT1 | 4245 | alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | P26572 |
C1306459 | Primary malignant neoplasm | ST8SIA3 | 51046 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | O43173 |
C1306459 | Primary malignant neoplasm | B4GALNT4 | 338707 | beta-1,4-N-acetyl-galactosaminyltransferase 4 | Q76KP1 |
C1306459 | Primary malignant neoplasm | CHST15 | 51363 | carbohydrate sulfotransferase 15 | Q7LFX5 |
C1306459 | Primary malignant neoplasm | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C1306459 | Primary malignant neoplasm | NDST4 | 64579 | N-deacetylase and N-sulfotransferase 4 | Q9H3R1 |
C1306459 | Primary malignant neoplasm | ST6GAL1 | 6480 | ST6 beta-galactoside alpha-2,6-sialyltransferase 1 | P15907 |
C1306459 | Primary malignant neoplasm | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C1306459 | Primary malignant neoplasm | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C1306459 | Primary malignant neoplasm | UGGT2 | 55757 | UDP-glucose glycoprotein glucosyltransferase 2 | Q9NYU1 |
C1306459 | Primary malignant neoplasm | POGLUT1 | 56983 | protein O-glucosyltransferase 1 | Q8NBL1 |
C1306459 | Primary malignant neoplasm | C1GALT1 | 56913 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | Q9NS00 |
C1306459 | Primary malignant neoplasm | GALNT11 | 63917 | polypeptide N-acetylgalactosaminyltransferase 11 | Q8NCW6 |
C1306459 | Primary malignant neoplasm | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C1306459 | Primary malignant neoplasm | ST3GAL4 | 6484 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 | Q11206 |
C1306459 | Primary malignant neoplasm | ST8SIA4 | 7903 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | Q92187 |
C1306459 | Primary malignant neoplasm | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C1306459 | Primary malignant neoplasm | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C1306459 | Primary malignant neoplasm | ST3GAL3 | 6487 | ST3 beta-galactoside alpha-2,3-sialyltransferase 3 | Q11203 |
C1306459 | Primary malignant neoplasm | OGT | 8473 | O-linked N-acetylglucosamine (GlcNAc) transferase | O15294 |
C1306459 | Primary malignant neoplasm | GALNT14 | 79623 | polypeptide N-acetylgalactosaminyltransferase 14 | Q96FL9 |
C1306459 | Primary malignant neoplasm | ST8SIA2 | 8128 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | Q92186 |
C1306459 | Primary malignant neoplasm | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C1306459 | Primary malignant neoplasm | CHPF | 79586 | chondroitin polymerizing factor | Q8IZ52 |
C1306459 | Primary malignant neoplasm | GPAA1 | 8733 | glycosylphosphatidylinositol anchor attachment 1 | O43292 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024